Google
 
Web globalrph.com
Home back Drug Search Drug Tables disclaimer IV Dilutions Medline Renal Dosing
calculators General links *Health topics* consumer links News online store
 
 
  infectious disease  - home

 




Search our
Health Library

 
Multimedia Library
More Health Topics

 


Bites Possible therapeutic alternatives 
Cat bite Common pathogens Augmentin 875 mg orally twice daily or  500mg three times daily  or Ceftin (cefuroxime oral) 500mg orally twice daily  or  Doxycycline 100mg orally twice daily
Dog bite Common pathogens Augmentin 875 mg orally twice daily or  500mg three times daily  //  or  if penicillin allergic: Adults: [Clindamycin 300mg orally every 6 hours + Ciprofloxacin 500mg twice daily]     Children: [clindamycin + Bactrim]
Human bite  Common pathogens Mild: Augmentin 875 mg orally twice daily or  500mg three times daily.  Moderate/severe: Ampicillin-sulbactam 1.5 to 3 grams IV every 6 hours or Ticarcillin-clavulanic acid  3.1 grams IV every 6 hours or Piperacillin-tazobactam 3.375 grams IV every 6 hours.  Penicillin allergy:  [Cipro or Bactrim] + clindamycin

 

Cat Bite

Human Bite

 

 

 

Antimicrobial Series
References

American Hospital Formulary Service.  Drug Information. Bethesda, MD: ASHP, 1997.
Baden LR, Eisenstein BI.Impact of Antibiotic Resistance on the Treatment of Gram-negative Sepsis.
Curr Infect Dis Rep. 2000 Oct;2(5):409-416.
Bartlett JG et al. Community-acquired pneumonia in adults: guidelines for management. Guidelines from the Infectious Diseases Society of America. Clin Infect Dis. 1998;26:811-38.
Bartlett JG: Empirical therapy of community-acquired pneumonia: macrolides are not ideal choices. Semin Respir Infect 1997 Dec; 12(4): 329-33
Bartlett JG.1998 Pocket Book of Infectious Disease Therapy., Ninth Edition. Baltimore,MD: Williams&Wikins,1998.
Bernstein JM: Treatment of community-acquired pneumonia--IDSA guidelines. Infectious Diseases Society of America. Chest 1999 Mar; 115(3 Suppl): 9S-13S
Drug Information Handbook, 5th Ed. 1997, Lexi-Comp inc. 
Ewig S et al. Pneumonia acquired in the community through drug-resistant Streptococcus pneumoniae. Am J Respir Crit Care Med. 1999;159:1835-42.
File TM Jr. Community-acquired pneumonia: recent guidelines for therapy. J Respir Dis. 1999;20:534-41.
Gilbert DN, Moellering RC, Sande MA. The Sanford Guide to Antimicrobial Therapy 2000. 30th ed. Hyde Park,VT: Antimicrobial Therapy, Inc.; 2000.
Gold HS, Moellering RC. Antimicrobial-drug resistance. N Engl J Med. 1996;335:1445-1453.
Gonzales R, Sande M: What will it take to stop physicians from prescribing antibiotics in acute bronchitis? Lancet 1995 Mar 18; 345(8951): 665-6
Hooton TM, Stamm WE. Diagnosis and treatment of uncomplicated urinary tract infection. Infect Dis Clin North Am 1997;11:551-581.
Lipsky BA, Berendt AR.Principles and practice of antibiotic therapy of diabetic foot infections.
Diabetes Metab Res Rev. 2000 Sep-Oct;16 Suppl 1:S42-6.
Mufson MA.Pneumococcal Pneumonia.
Curr Infect Dis Rep. 1999 Apr;1(1):57-64.
Reese RE, Betts RF: A Practical Approach to Infectious Diseases. 4th ed. Boston: Little, Brown, and Company; 1996: 251
Stefani SD, Cadore LP, Villaroel RU, Azevedo S, Machado AL. Antibiotic Selection in the Treatment of Febrile Neutropenia: Current Approach and New Directions.
Braz J Infect Dis. 1998 Jun;2(3):109-117.
Stamm WE, Hooton TM. Management of urinary tract infections in adults. N Engl J Med 1993;329:1328-1334.

-

 

 

 

 
Contact . Privacy PolicyDisclaimer

Copyright  © 2005 GlobalRPh Inc.